Investors
Dear Shareholders,
As we close another remarkable chapter in Mold-Tek’s journey, I am pleased to share my reflections on what has been a pivotal year for our organization. We not only expanded plant capacities at Panipat, Cheyyar and Satara but also created our first plant for pharma packaging at Sultanpur. In less than 12 months, this new Pharma division not only achieved break-even but also turned profitable, an achievement that speaks volumes about our strategic foresight, execution and marketing abilities. This segment holds immense promise, and we are excited about its market potential, especially as we prepare to launch new and custom built products in this space.
I am pleasantly surprised to find a yawning gap in Pharma packaging field, especially the lack of agility in new product development. Given our strengths of in-house product and mold designing coupled with world class tool-room, we hope to capture sizeable business in pharma packing in next few years.
Financial Performance: The global and domestic economic landscape in FY 2024–25 was shaped by uncertainty—tariffs, ongoing geopolitical tensions, inflationary pressures, and cautious consumer spending. Despite these headwinds, Mold-Tek demonstrated resilience and agility. Our Revenue from operations stood strong at ₹78,132 lakhs up by 11.83% from ₹69,865 lakhs in FY 2023-24. Whereas EBIDTA rose to ₹14,386 lakhs, an increase of 6.98% over the previous year’s ₹13,448 lakhs. This steady growth is a testament to our robust business fundamentals and our ability to adapt quickly to dynamic market conditions.
Segment wise performance: Our product segments delivered differentiated performance during the year. The Square Packs segment achieved a growth of 22%, while the Food & FMCG Packs segment grew by 9.58%. The Lubes-Packs segment reported just 1% growth, and the Paints-Pack segment growth stood at 13.39%. Most notably, the Pharma Packaging division registered impressive growth to standout as it started contributing to the Company’s growth in the inaugural year itself. We are soon starting Food and FMCG (Fast Moving Consumer Goods) products plant at Panipat, to cater to the needs of North Based Clients. This plant will be functional by September 2025 and will be ramped up by March 2026. This move should sustain our growth in Food and FMCG segment in future.
Strategic Positioning: Our diverse product portfolio including Q-packs, FMCG containers, pails and now pharma packaging continues to be a cornerstone of our stability and growth. Our in-house tool room is our backbone, giving us a competitive advantage, enabling us to rapidly implement design changes and customizations in alignment with client specifications. Mold-Tek currently operates manufacturing facilities across India. These plants are equipped with advanced infrastructure, giving us a critical edge in optimizing delivery times, reducing costs, and enhancing customer satisfaction.
Customer Trust: With over four decades of experience in packaging industry, I can proudly say that we’ve built lasting relationships with our clients grounded on trust, consistent product quality, and responsiveness to evolving needs. Our deep understanding of market trends and client expectations, empower us to deliver tailored, value-added packaging solutions. As we continue to serve our marquee clients, we are equally focused on expanding our customer base and solidifying Mold-Tek’s footprint as a leading supplier of a wide range of packaging solutions.
Future Outlook: The huge investments and capacities built by the Company in the last three years have started bearing fruit. As we look ahead, our focus remains on better utilization of our manufacturing capacities, exploring export opportunities, launching new and differentiated products and driving R&D initiatives. We are optimistic about the road ahead. We are confident that our initiatives will help us deliver sustainable, long-term growth and create enduring value for our stakeholders. I thank you for your continued trust and support. Together, let us look forward to another year of purposeful growth and meaningful achievements.
J. LAKSHMANA RAO Chairman and Managing Director
Contact Details
Company Secretary & Compliance Officer
Ms.Harshita Suresh Chandnani
8-2-293/82/A/700, Road No. 36,
Jubilee Hills, Hyderabad – 500033
Telangana, India.
Phone No: +91 40 40300323
Fax .No. : +91 40 40300328
E-Mail: cs@moldtekpackaging.com
Investor Relations Department
Mr. Mallikarjun / Dy. Nodal Officer
8-2-293/82/A/700, Road No. 36,
Jubilee Hills, Hyderabad – 500033
Telangana, India.
Phone No: +91 40 40300330
Fax .No. : +91 40 40300328
E-Mail: ir@moldtekpackaging.com
M/s. KFin Technologies Limited
UNIT–Mold-Tek Packaging Limited
Selenium Building, Tower-B, Plot No.: 31 & 32,
Financial District,Nanakramguda,Serilingampally
Hyderabad,Rangareddi,Telangana,India-500032
Landline Number: +91-40-67162222 / 7961 1000
Toll Free Number: 1800 309 4001
WhatsApp Number: (91) 910 009 4099
Fax. No : +91 40 23553214
E-Mail ID : einward.ris@kfintech.com
Website : www.kfintech.com
Investor Support Centre Link : https://ris.kfintech.com/clientservices/isc/default.aspx
Bankers
Citibank N.A., ICICI Bank Ltd.
Statutory Auditors
M/s. M. Anandam & Co.
Chartered Accountants
7 ‘A’, Surya Towers, Sardar Patel,
Road, Secunderabad-500 003
Internal Auditors
M/s. Praturi & Sriram
Chartered Accountants
3-6-220, Street No.15,
Himayatnagar,
Hyderabad - 500 029
Secretarial Auditor
Mr. Ashish Kumar Gaggar
Company Secretary in Practice
Flat No.201, IInd Floor,
Lake View Towers, Safari Nagar,
Kothaguda, Kondapur, Hyderabad-500085
Stock Exchange(s) where the shares of the company are listed
Mold-Tek Packaging Ltd. - BSE Ltd. (BSE) (Scrip Code: 533080) Click Here
Mold-Tek Packaging Ltd. – National Stock Exchange of India Ltd. (NSE) (Symbol: MOLDTKPAC)
Click Here-
Quarterly Results

-
Shareholding Pattern

-
AGM / EGM / Annual Reports

-
Notice, Ads and Other Stock Exchange Disclosures

-
Voting Results

-
Unclaimed Dividend List

-
Transfer of shares to IEPF

-
Subsidiary Financial Results

-
Audio-Video Recordings/Transcripts

| Financial reporting for | Tentative Date |
|---|---|
| Audited results for year ending on 31st March, 2025 | On or before 30th May, 2025 |
| Unaudited results for quarter ending on 31st December, 2024 | On or before 14th February, 2025 |
| Unaudited results for quarter ending on 30th September, 2024 | On or before 14th November, 2024 |
| Unaudited results for quarter ending on 30th June, 2024 | On or before 14th August, 2024 |
